Advanced Gastric and Colorectal Cancer Diagnosis and Treatment
Management strategies aimed at improving outcomes in patients with CRC and gastric cancer were presented at the 2023 ONA Summit.
Management strategies aimed at improving outcomes in patients with CRC and gastric cancer were presented at the 2023 ONA Summit.
Adding pembrolizumab to frontline chemotherapy improves outcomes in patients with HER2-negative, advanced gastric or GEJ cancers, a phase 3 trial suggests.
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
Implementation of precision oncology recommendations has clinical utility for patients with gastrointestinal cancers.
Researchers explored the potential relationship between bariatric surgery for severe obesity and risk of esophageal and gastric cancers.
Researchers sought to determine which of 4 well-known prognostic scoring systems were more accurate in patients with advanced GE cancer.
A systematic review and meta-analysis sought to determine the risk of secondary primary cancer for survivors of colorectal cancer.
At five years, OS, RFS similar for laparoscopic surgery and open distal gastrectomy for locally advanced gastric cancer.
Smoking and rural residence are most strongly associated with gastrointestinal cancer-related mortality.
Age at diagnosis, sex, histology, stage T, surgery, tumor size, and marital status were independently prognostic of overall survival.